V-Square Quantitative Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$388K Sell
5,354
-843
-14% -$60.7K 0.04% 407
2026
Q2
$438K Buy
6,197
+941
+18% +$50.8K 0.04% 363
2026
Q1
$275K Buy
5,256
+50
+1% +$3K 0.03% 459
2025
Q4
$306K Buy
+5,206
New +$316K 0.03% 428
2025
Q3
– Sell
-5,145
Closed -$265K – 540
2025
Q2
$265K Sell
5,145
-104
-2% -$5.23K 0.04% 452
2025
Q1
$308K Buy
5,249
+757
+17% +$51.3K 0.04% 401
2024
Q4
$324K Sell
4,492
-15
-0.3% -$1.1K 0.05% 399
2024
Q3
$360K Buy
4,507
+7
+0.2% +$526 0.05% 381
2024
Q2
$322K Buy
4,500
+406
+10% +$29.9K 0.05% 353
2024
Q1
$288K Hold
4,094
– – 0.04% 389
2023
Q4
$316K Buy
4,094
+641
+19% +$42.2K 0.06% 301
2023
Q3
$235K Buy
3,453
+2,457
+247% +$194K 0.1% 258
2023
Q2
$81.3K Buy
+996
New +$80.1K 0.06% 248

Other funds holding TECH

V-Square Quantitative Management's TECH Position: Q3 2026 in Review

V-Square Quantitative Management reduced its Bio-Techne (TECH) stake by 14% in Q3 2026, selling an estimated $60.7K and leaving 5,354 shares worth $388K. The position accounts for 0.04% of the portfolio, ranked #407.

V-Square Quantitative Management first reported a position in TECH in Q2 2023 and has held it in 13 quarters since. The position peaked at $438K in Q2 2026. 59 funds tracked by Wall St. Rank hold TECH as of Q3 2026.

  • V-Square Quantitative Management held 5,354 shares of Bio-Techne worth $388K as of Q3 2026.
  • V-Square Quantitative Management sold 843 Bio-Techne shares in Q3 2026, an estimated $60.7K.
  • Bio-Techne made up 0.04% of V-Square Quantitative Management's portfolio in Q3 2026, its #407 holding.
  • V-Square Quantitative Management first reported a position in Bio-Techne in Q2 2023 and has held it in 13 quarters since.
  • V-Square Quantitative Management's Bio-Techne position peaked at $438K in Q2 2026.
  • 59 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2026.

Based on V-Square Quantitative Management's 13F filing for Q3 2026, filed 15 Oct 2026.